Clinical Trial Update: An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial [Phase 2]

View source ↗

Summary

A completed Phase 2 open-label follow-on study conducted across multiple centers. It evaluated safety and tolerability of inhaled insulin in adults with Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2014-10-16